|Education||University of Turin, Italy|
|Known for||former CEO and founder of Advanced Accelerator Applications (AAA) - NASDAQ: AAAP|
Stefano Buono (born 1966) is an accomplished Italian physicist and alumnus of The European Organization for Nuclear Research (CERN). For 15 years Mr. Buono has served as Chief Executive Officer and board member of Advanced Accelerator Applications (AAA), an international radiopharmaceutical company he founded in 2002.
Career as physicist
Prior to founding Advanced Accelerator Applications in 2002, Stefano Buono worked as a physicist at the Centre for Advanced Studies, Research and Development or CRS4. During his six years within CRS4, he headed a team of engineers working on different international research projects in the field of energy production and nuclear waste transmutation (Accelerator-Driven Systems). Before joining CRS4 and in parallel to his appointment at CRS4, Stefano Buono worked for approximately ten years with physics Nobel laureate Carlo Rubbia at CERN, one of the leading research laboratory for particle physics in the world. During that term, he also actively participated in the development of CERN's Adiabatic Resonance Crossing method.. He is also the author of numerous scientific publications.
Advanced Accelerator Applications
In 2002, Stefano Buono founded Advanced Accelerator Applications (NASDAQ: AAAP), a radiopharmaceutical company that develops, produces and commercializes molecular nuclear medicine, diagnostic and therapeutic products. Today AAA trades on the Nasdaq Global Select Market under the ticker “AAAP.” The first day of trading was 11 November 2015. Following the 2018 acquisition of AAA by Novartis for $3.9 billion, Mr. Buono serves as a consultant to the company.
- Sviluppo: ITSPlanet S.r.l. "Advanced Accelerator Applications - AAA". Adacap.com. Retrieved 18 December 2014.
- "Stefano Buono: Executive Profile & Biography - Businessweek". Businessweek.com. Retrieved 18 December 2014.
- "Publications de Buono au CRS4". Publications.crs4.it. Retrieved 18 December 2014.
- "Advanced Accelerator Applications Acquires GE Healthcare’s FDG-PET Radiopharmaceutical Business in Italy", Diagnostic and Interventional cardiology, September 2014